Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

Analyst Ratings

Analyst Ratings for Bank OZK

By Benzinga Insights

September 27, 10:01 AM

Analysts have provided the following ratings for Bank OZK (NASDAQ:OZK) within the last quarter: Bullish Somewhat Bullish Indifferent…

OZK

Enterprise Bancorp Q3 EPS $0.98 Up From $0.81 YoY

By Benzinga Newsdesk

October 20, 4:03 PM

Enterprise Bancorp (NASDAQ:EBTC) reported quarterly earnings of $0.98 per share. This is a 20.99 percent increase over earnings of $0.81 per share from the same period last year.

EBTC

Analyst Ratings

Where Synaptics Stands With Analysts

By Benzinga Insights

July 26, 12:00 PM

Analysts have provided the following ratings for Synaptics (NASDAQ:SYNA) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

SYNA

Global
News

Uber Eats Announces Exclusive Delivery Partnership With Domino’s In Canada

By Benzinga Newsdesk

April 30, 10:04 AM

Unprecedented global agreement provides new ordering option for Canadian customers, with deliveries handled by Domino's delivery expertsTORONTO, April 30, 2024 /CNW/ - Uber Eats (NYSE:UBER) announced that hungry

DPZ

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Related Posts

Analyst Ratings for Bank OZK

Enterprise Bancorp Q3 EPS $0.98 Up From $0.81 YoY

Where Synaptics Stands With Analysts

Uber Eats Announces Exclusive Delivery Partnership With Domino’s In Canada